Trust Company’s Celgene Corp CELG Stock Holding History

Trust Company’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-132	Closed	-$12K	–	343
2019 Q1	$12K	Sell	132 -48,256	-100%	-$4.22M	0.01%	271
2018 Q4	$3.1M	Buy	48,388 +48,254	+36,010%	+$3.56M	1.73%	29
2018 Q3	$12K	Sell	134 -365	-73%	-$32.3K	0.01%	263
2018 Q2	$40K	Sell	499 -45,605	-99%	-$3.79M	0.02%	180
2018 Q1	$4.11M	Buy	46,104 +46,064	+115,160%	+$4.42M	1.52%	22
2017 Q4	$4K	Hold	40	–	–	﹤0.01%	341
2017 Q3	$6K	Hold	40	–	–	﹤0.01%	268
2017 Q2	$5K	Hold	40	–	–	﹤0.01%	293
2017 Q1	$5K	Hold	40	–	–	﹤0.01%	316
2016 Q4	$5K	Hold	40	–	–	﹤0.01%	327
2016 Q3	$4K	Hold	40	–	–	﹤0.01%	359
2016 Q2	$4K	Hold	40	–	–	﹤0.01%	329
2016 Q1	$4K	Hold	40	–	–	﹤0.01%	320
2015 Q4	$4.79K	Hold	40	–	–	﹤0.01%	308
2015 Q3	$4K	Hold	40	–	–	﹤0.01%	341
2015 Q2	$5K	Hold	40	–	–	﹤0.01%	325
2015 Q1	$5K	Buy	+40	New	+$4.78K	﹤0.01%	270

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Trust Company's CELG Position: Q2 2019 in Review

Trust Company sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 132 shares — an estimated $12K sold.

Trust Company first reported a position in CELG in Q1 2015 and held it in 17 quarters. The position peaked at $4.11M in Q1 2018. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Trust Company reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Trust Company sold 132 Celgene Corp shares in Q2 2019, an estimated $12K.
Trust Company first reported a position in Celgene Corp in Q1 2015 and held it in 17 quarters.
Trust Company's Celgene Corp position peaked at $4.11M in Q1 2018.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Trust Company's 13F filing for Q2 2019, filed 8 Jul 2019.